The Diagnostic Pathology of the Nuclear Envelope in Human Cancers

被引:20
作者
Fischer, Andrew H. [1 ]
机构
[1] Univ Massachusetts, Dept Pathol, Mem Med Ctr, Worcester, MA 01605 USA
来源
CANCER BIOLOGY AND THE NUCLEAR ENVELOPE: RECENT ADVANCES MAY ELUCIDATE PAST PARADOXES | 2014年 / 773卷
关键词
Criteria of malignancy; Histogenetic classification; Hallmarks of cancer; Relation between oncogenes; Nuclear envelope morphology; PAPILLARY THYROID-CARCINOMA; INTRANUCLEAR CYTOPLASMIC INCLUSIONS; PROLIFERATIVE ACTIVITY; MICROSATELLITE INSTABILITY; MOLECULAR-GENETICS; CELL; MECHANISMS; EXPRESSION; FEATURES; ORIGIN;
D O I
10.1007/978-1-4899-8032-8_3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer is still diagnosed on the basis of altered tissue and cellular morphology. The criteria that pathologists use for diagnosis include many morphologically distinctive alterations in the nuclear envelope (NE). With the expectation that diagnostic NE changes will have biological relevance to cancer, a classification of the various types of NE structural changes into three groups is proposed. The first group predicts chromosomal instability. The changes in this group include pleomorphism of lamina size and shape, as if constraints to maintain a spherical shape were lost. Also characteristic of chromosomal instability are the presence of micronuclei, a specific structural feature likely related to the newly described physiology of chromothripsis. The second group is predicted to be functionally important during clonal evolution, because the NE changes in this group are conserved during the clonal evolution of genetically unstable tumors. Two examples of this group include increased ratio of nuclear volume to cytoplasmic volume and the relatively fragile nuclei of small-cell carcinomas. The third and most interesting group develops in a near-diploid, genetically stable background. Many of these (perhaps ultimately all) are directly related to the activation of particular oncogenes. The changes in this group so far include long inward folds of the NE and spherical invaginations of cytoplasm projecting partially into the nucleus ("intranuclear cytoplasmic inclusions"). This group is exemplified by papillary thyroid carcinoma in which RET and TRK tyrosine kinases, and probably B-Raf mutations, directly lead to diagnostic longitudinal folds of the lamina ("nuclear grooves") and intranuclear cytoplasmic inclusions. B-Raf activation may also be linked to intranuclear cytoplasmic inclusions in melanoma and to nuclear grooves in Langerhans cell histiocytosis. Nuclear grooves in granulosa cell tumor may be related to mutations in the FOXL2 oncogene. Uncovering the precise mechanistic basis for any of these lamina alterations would provide a valuable objective means for improving diagnosis, and will likely reflect new types of functional changes, relevant to particular forms of cancer.
引用
收藏
页码:49 / 75
页数:27
相关论文
共 73 条
  • [1] [Anonymous], CELL HLTH DIS EVALUA
  • [2] Cytological detection of papillary thyroid carcinomas by nuclear membrane decoration with emerin staining
    Asioli, Sofia
    Maletta, Francesca
    Pacchioni, Donatella
    Lupo, Rosanna
    Bussolati, Gianni
    [J]. VIRCHOWS ARCHIV, 2010, 457 (01) : 43 - 51
  • [3] Emerin immunohistochemistry reveals diagnostic features of nuclear membrane arrangement in thyroid lesions
    Asioli, Sofia
    Bussolati, Gianni
    [J]. HISTOPATHOLOGY, 2009, 54 (05) : 571 - 579
  • [4] Recurrent BRAF mutations in Langerhans cell histiocytosis
    Badalian-Very, Gayane
    Vergilio, Jo-Anne
    Degar, Barbara A.
    MacConaill, Laura E.
    Brandner, Barbara
    Calicchio, Monica L.
    Kuo, Frank C.
    Ligon, Azra H.
    Stevenson, Kristen E.
    Kehoe, Sarah M.
    Garraway, Levi A.
    Hahn, William C.
    Meyerson, Matthew
    Fleming, Mark D.
    Rollins, Barrett J.
    [J]. BLOOD, 2010, 116 (11) : 1919 - 1923
  • [5] Biesterfeld S, 2003, ANTICANCER RES, V23, P4269
  • [6] Bignold L P., 2006, Cancer: Cell Structures, Carcinogens and Genomic Instability, P1
  • [7] BOND JA, 1994, ONCOGENE, V9, P281
  • [8] Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
    Borrello, MG
    Alberti, L
    Fischer, A
    Degl'Innocenti, D
    Ferrario, C
    Gariboldi, M
    Marchesi, F
    Allavena, P
    Greco, A
    Collini, P
    Pilotti, S
    Cassinelli, G
    Bressan, P
    Fugazzola, L
    Mantovani, A
    Pierotti, MA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (41) : 14825 - 14830
  • [9] Boveri T, 2007, ORIGIN MALIGNANT TUM
  • [10] Bozzetti C, 1996, DIAGN CYTOPATHOL, V15, P116, DOI 10.1002/(SICI)1097-0339(199608)15:2<116::AID-DC6>3.0.CO